SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011326
Filing Date
2021-05-13
Accepted
2021-05-13 16:50:29
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 480507
2 ex31-1.htm EX-31.1 12047
3 ex31-2.htm EX-31.2 11828
4 ex32-1.htm EX-32.1 8572
  Complete submission text file 0001493152-21-011326.txt   3302837

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE eton-20210331.xml EX-101.INS 416836
6 XBRL SCHEMA FILE eton-20210331.xsd EX-101.SCH 38797
7 XBRL CALCULATION FILE eton-20210331_cal.xml EX-101.CAL 48217
8 XBRL DEFINITION FILE eton-20210331_def.xml EX-101.DEF 205939
9 XBRL LABEL FILE eton-20210331_lab.xml EX-101.LAB 327580
10 XBRL PRESENTATION FILE eton-20210331_pre.xml EX-101.PRE 258232
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 21920433
SIC: 2834 Pharmaceutical Preparations